WeVote
Log In

Bill

Bill

HB 672

Public Health - Maryland Pediatric Cancer Fund - Entities Eligible for Grants

2026 Regular Session Introduced by Tiffany Alston and 16 co-sponsors

HB 672 expands Maryland's Pediatric Cancer Fund eligibility criteria, allowing more entity types to compete for state grants supporting pediatric cancer services and research.

Approved by the Governor - Chapter 220
0
WeVote Research Nonpartisan
Bill Summary · HB 672

Legislative bill overview

HB 672 modifies Maryland's Pediatric Cancer Fund by expanding the types of entities eligible to receive grant funding. The bill appears to broaden eligibility criteria beyond the original restrictions, allowing additional organizations to apply for and receive state funds dedicated to pediatric cancer research, treatment, or support services.

Why is this important

Pediatric cancer affects Maryland families directly, and expanding fund eligibility can increase access to services and research opportunities across more organizations. However, the specific eligibility changes determine whether this meaningfully expands care capacity or redistributes limited funds among more competitors, potentially diluting impact per recipient.

Potential points of contention

  • Funding dilution concerns – Expanding eligible entities without increasing total funding could spread limited resources thinner, reducing grant amounts per organization
  • Accountability and oversight standards – Broader eligibility may require clearer metrics to ensure grants support legitimate pediatric cancer initiatives rather than tangential programs
  • Geographic equity – Unclear whether expanded eligibility prioritizes underserved areas or inadvertently concentrates funding in regions with more established organizations able to navigate grant processes

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.